WHO HIV Guidelines Adopted Last Where They Would Make the Biggest Difference, Study Finds

Analysis of National Policies Also Notes That Implementation Lag Also Leads to Missed Prevention and Life-Saving Opportunities

September 8, 2016

When the World Health Organization issued an early update to its HIV treatment guidelines in September 2015, the new recommendations drew on years of mounting evidence that immediate antiretroviral treatment for people diagnosed with the virus saves lives, prevents transmission, averts serious illnesses, and is essential to control of the pandemic. In fact, by then,18 high- and middle income countries that include the United States already had adopted policies that reflected their recognition of the benefits early treatment offers individual and public health. Nearly a year after the release of the WHO update, however, only three countries in sub-Saharan Africa have adopted the latest guidelines as their criteria for treatment access.

That lag reflects a trend that has slowed treatment access and progress against HIV in countries with the greatest numbers of people living with the virus, say authors of a report published this week in the Southern African Journal of HIV Medicine. Their study examined the amount of time between the issuance of WHO’s 2009, 2013 and 2015 guidelines, and national policies adopting them across 33 sub-Saharan African countries. Although each change in WHO guidelines reflected an accumulated consensus of best practices that had been evaluated by experts and supported by evidence, adoption of the guidelines has been slow, authors found.

Countries took an average of two years to adopt 2009 guidelines recommending people with HIV start treatment when their CD4 — or immune cell — counts dropped to 350 per cubic millimeter of blood, rather than waiting until their immune systems were more damaged, as previous guidelines had indicated, with counts of 200 or below. Three years after the release of 2013 guidelines that treatment should start earlier, when immune cell counts dropped to 500 or below, 11 countries, including some with the highest rates of infection, have yet to incorporate the recommendations into their national policies.

This excerpt was cross-posted with the permission of Science Speaks. Read the full article.

Related Stories

WHO Flags Key Challenges to Global HIV Response at International AIDS Conference
WHO Confirms Antiretroviral Therapy Reduces the Risk of Life-Threatening HIV-Related Infections
Treat All People Living With HIV, Offer Antiretrovirals as PrEP for People at Substantial Risk

This article was provided by Science Speaks. Visit Science Speaks' website to find out more about their activities and publications.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.